2021 Student Scholarship – Second Place Case Study MATTHEW RENSHAW RUDDELL, ND LESLIE FULLER, ND Paroxysmal kinesigenic dyskinesia (PKD) is the most common paroxysmal movement disorder and is [...]

Vis Medicatrix Naturae Todd A. Born, ND, CNS Mood disorders are mental health issues that primarily impact a person’s emotional state; an affected person may experience periods of extreme [...]

Node Smith, ND Ketamine has gotten a bad rap as an opioid when there’s plenty of evidence suggesting it isn’t one, Johns Hopkins experts say. They believe this reputation may hamper patients from [...]

Tolle Causam Decker Weiss, NMD, FASA It is debatable whether dementia is on the rise. According to the Alzheimer’s Association, brain disease and dementia are on the rise across all 50 US states, [...]

Node Smith, ND Schizophrenia causes hallucinations and memory or cognition problems inter alia. This psychiatric illness affects 0.5% of the general population, and it may be related to genetic [...]

Node Smith, ND Genetic testing may be the next method used to predict cognitive performance. The technology has been developed, and the United States Military is beginning to “play” with it. [...]

Node Smith, ND A new research study from Australia – Curtin University – is looking into the use of N-Acetyl Cysteine (NAC) for the treatment of methamphetamine addiction.1 A clinical [...]

Carrie Decker, ND Tolle Causam Potential Physiological Mediators Supporting patients who experience anxiety, depression, and insomnia often is a long and arduous challenge for both the patient [...]

Therapeutic Potential in SLE, MS & Systemic Sclerosis Kimberly M. Sanders, ND N-acetylcysteine (NAC) is an amino acid derivative that is a well-known mucolytic and antioxidant. Its [...]

Bradley Bush, ND Anxiety disorder is a generic blanket term outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) that includes [...]